John Simmons

John Simmons is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Global Vice President of Biopharma at Natera, a position he has held since September 2020.1 His career trajectory showcases a strong background in translational medicine and diagnostics, particularly in the field of cancer research.

Professional Experience

Prior to his current role at Natera, Simmons held several positions at Personal Genome Diagnostics:

• VP of Translational Medicine (January 2019 - September 2020)
• Director of Translational Science & Diagnostics (November 2016 - January 2019)
• Manager of Translational Science & Diagnostics (January 2016 - October 2016)1

His experience also includes significant time at the National Cancer Institute (NCI):

• Postdoctoral Fellow (March 2014 - January 2016)
• Predoctoral Fellow (June 2009 - March 2014)
• Post-Bac Fellow (May 2006 - May 2009)1

Education

Simmons holds a strong academic background:

• Doctor of Philosophy (Ph.D.) in Tumor Biology from Georgetown University School of Medicine
• Bachelor of Science (BS) in Biology, with University Honors, from American University (2002-2006)1

Research Interests

During his time at the NCI, Simmons focused on combining experimental and bioinformatics approaches to identify and validate novel therapeutic targets and drug combinations in multiple myeloma. His research involved integrating gene expression profiling and other high-throughput genetic techniques across various models and patient cohorts.1

Achievements and Awards

Throughout his career, Simmons has received numerous accolades, including:

• Multiple Myeloma Research Foundation (MMRF) Research Fellow Award (2014)
• NIH Fellows Award for Research Excellence (FARE) (2014)
• Federal Technology Transfer Awards (2012 and 2014)
• Several scholar-in-training awards from prestigious organizations1

John Simmons is currently based in Boston, Massachusetts, and has over 500 connections on LinkedIn.1